Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
10 January 2014 09:27
The first once-daily asthma inhaler has been granted approval for use in Britain
The first ever once-a-day asthma inhaler has been approved for use in Britain.
Relvar Ellipta is the name of the new drug, which uniquely combines a steroid dose to reduce inflammation with a new type of long-acting beta2 agonist to open the airways.
Anyone with asthma travel insurance who is planning to book a dream holiday in 2014 may be hopeful that the new medicine could represent a more convenient and effective way to keep their condition under control.
Some people with asthma will even be able to dispense with their blue inhaler, although others will need to continue to also carry one for when they require immediate relief.
Relvar Ellipta has been approved by the European Commission for prescribing by GPs and asthma specialists to adults and adolescents aged 12 and over, though the NHS drug watchdog NICE is yet to evaluate its cost effectiveness.
The new inhaler can also be used by thousands of people living with the lung disease COPD.
Before granting approval, the European Medicines Agency reviewed results from 10 clinical studies involving 7,783 patients with COPD and 16 trials in 9,326 patients with asthma.
Research has revealed that patients use the grey palm-sized device correctly from the outset and up to six weeks later.
The new treatment offers 24-hour help to asthmatics, many of whom are currently failing to keep the condition under control.
Asthma is an inflammatory disease that constricts the airways and the resulting attacks of breathlessness can be fatal.
More than five million Britons are affected by the condition and many of them experience moderate to severe problems.
Up to three out of four of these patients with moderate to severe problems have "uncontrolled" symptoms despite using one inhaler designed to combat an attack and a second inhaler to keep the airways open.
15 January 2019
NHS commissioners could be slapped with a £2,500 fine for every patient left waiting more than a year for vital care, new proposals suggest.
[more...]
12 January 2019
All UK airports should buy anti-drone technology and not rely on the Royal Air Force to help out, Defence Secretary Gavin Williamson has said.
10 January 2019
The military was brought in on Tuesday night after police officers saw a drone operating at Heathrow Airport, forcing departures to be suspended for an hour.
11 January 2019
A so-called "drug sponge" that mops up leftover drugs from cancer treatment could improve the effectiveness of chemotherapy, new research has claimed.
09 January 2019
A hormone released during exercise could help protect the brain from Alzheimer's disease, new research suggests.
08 January 2019
Ryanair has been labelled the worst airline operating in the UK for the sixth year running in a leading consumer group survey.
05 January 2019
Anti-drone technology will be deployed at the UK's two busiest airports in response to the disruption caused before Christmas.
04 January 2019
A new cancer-detecting breathalyser test is being trialled in the UK - in a move that could revolutionise the way the disease is diagnosed.
03 January 2019
The average 10-year-old child will have already eaten more sugar in their life than the maximum amount recommended for 18-year-olds, a new study reveals.
01 January 2019
The number of travellers satisfied with flying has fallen over the last two years over frustration with how airlines handle complaints, new research reveals.
25 December 2018
People are being encouraged to connect with friends, neighbours and others in their community this Christmas to help tackle loneliness.
29 December 2018
Nearly 300 travellers have been arrested over the past two years for being drunk at an airport or on a plane.